Priser
Platform
Blog
Om os
Download
Medondo Holding
Medondo Holding
Deutsche Börse Xetra
0

Om

Medondo Holding AG is a company dedicated to advancing digital solutions specifically for the healthcare industry. It primarily focuses on developing comprehensive software systems that improve the efficiency of medical practices and healthcare providers. Medondo provides a wide array of services including practice management software, which encompasses appointment scheduling, patient record management, and billing solutions, all tailored to streamline medical office operations. This integration is crucial for enhancing patient care, reducing administrative burdens, and ultimately optimizing workflow within healthcare facilities. By leveraging technology, Medondo Holding AG plays a significant role in transforming traditional healthcare practices into more adaptable and intelligent systems, ensuring seamless interaction between medical professionals and patients. As the healthcare sector continues to evolve with ongoing digital transformation, Medondo remains an impactful player, contributing to the modernization and technological advancement of this essential industry.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I MEDONDO HOLDING MED ENDAVU: Køb Medondo Holding ($AMI) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Medondo Holding, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerAMI
Land
Tyskland
Hjemmesideholding.medondo.com
SektorTeknologi
IndustriInformationsteknologitjenester

Analytikerskøn

Baseret på 1 analytiker

Stærkt købKøbHoldSælgStærkt sælg
0%100%0%0%0%